Drugs / Phyllanthus Urinaria
Phyllanthus Urinaria
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not stated1 trial | ||||||
| — | NCT01198860 | — | chronic hepatitis B virus infection | Nguyen Thi Trieu, MD | Approved for marketing | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT01210989 Comparator | May 2010 → May 2012 | NAFLD1 | Chinese University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phyllanthus Urinaria | “Drug: * Tenofovir * Phyllanthus Urinaria * Adenosma Glutinosum * Eclipta Prostrata * Ascorbic Acid” NCT01198860 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Phyllanthus urinaria is a commonly used hepatoprotective herb” PMID 23034128 ↗ Jan 2013 |
| Route | Oral | “receive oral Hepaguard 1 g three times daily” NCT01210989 ↗ |